Brief: Timber Pharmaceuticals Announces Pricing Of $8.0 Million Public Offering
04/08/2022 14:33
Aug 4 (Reuters) - Timber Pharmaceuticals Inc TMBR.A :
* TIMBER PHARMACEUTICALS ANNOUNCES PRICING OF $8.0 MILLION
PUBLIC
OFFERING
* TIMBER PHARMACEUTICALS - OFFERING PRICE TO PUBLIC OF $0.12
PER
SHARE AND ASSOCIATED WARRANT
Source text for Eikon: ID:nGNX2YzFWf
Further company coverage: TMBR.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Trex Wind-Down
See all newsBrief: NYSE American To Suspend Trading Immediately In Timber Pharma
Brief: Timber Pharmaceuticals Receives Court Approval Of All “First Day” Motions To Support Business
Brief: NYSE American to Commence Delisting Proceedings Against Timber Pharmaceuticals
Brief: Timber Pharmaceuticals Says Prior To Filing Of Chapter 11 Case, Debtors Entered Into A "Stalking Horse" Asset Purchase Agreement
Brief: Timber Pharmaceuticals Inc Files For Voluntary Chapter 11 Bankruptcy - Court Filing